Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Share News (POLX)

Share Price Information for polarean (POLX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.325
Bid: 1.30
Ask: 1.35
Change: 0.00 (0.00%)
Spread: 0.05 (3.846%)
Open: 1.325
High: 1.325
Low: 1.275
Prev. Close: 1.325
POLX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Sharp profit performance from Gem Diamonds, Headlam

Thu, 02nd Sep 2021 13:20

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Headlam Group PLC - Birmingham-based floor coverings - For the six months ended June, reports pretax profit of GBP14.0 million, swinging from a loss of GBP24.5 million a year prior, driven by a 45% year-on-year rise in revenue to GBP329.9 million from GBP227.2 million, nearly reaching GBP335.0 million reported for the first half of 2019. Revenue growth was driven by a recovery in the higher margin residential sector. Resumes normalised dividends with 5.8 pence per share. Looking ahead, commercial sector activity remans subdued, with residential performance pleasing, company remains in line with market expectations.

----------

Gem Diamonds Ltd - Lesotho and Botswana-focused diamond miner - For the first half of 2021, pretax profit rises sharply to USD28.3 million from USD2.5 million, on revenue which grew 50% year-on-year to USD104.5 million from USD69.5 million. During the period, ore mined rose to 3.18 million tonnes from 2.49 million tonnes, leading to the recovery of 58,831 carats compared to 43,275 carats, and an average sale price of USD1,886 per carat from USD1,707.

----------

Integrated Diagnostics Holdings PLC - consumer healthcare firm with operations in Egypt, Jordan, Sudan, and Nigeria - For the first half of 2021, pretax profit sharply rises to EGP1.04 billion - around GBP47.8 million - from EGP269.7 million, on revenue which more than doubled to EGP2.29 billion from EGP949.7 million, due to a 45% rise in the amount of tests performed to 1.45 million and 66% increase in the average price per test to EGP141. Declares an interim dividend of USD0.048 per share

----------

Polarean Imaging PLC - North Carolina-based MRI equipment developer and manufacturer - For the first half of 2021, pretax loss widens to USD4.9 million from USD3.2 million a year before, due to a sharp rise in selling and administration costs to USD1.8 million from USD351,754. Widened loss was in spite of revenue nearly doubling to USD621,874 from USD327,896 on the sale of a polariser system to MD Anderson.

----------

Gym Group PLC - low cost gyms operator - For the six months ended June 30, pretax loss barely narrows to GBP28.5 million from GBP28.6 million the year before, as administration costs remain high at GBP54.6 million, and revenue declines 21% to GBP29.3 million from GBP37.3 million, reflecting the extended lockdown in early 2021 which meant that gyms were only open for two full months of the trading period. However, membership numbers at the end of June rose to 730,000 from 698,000 a year prior. Looking ahead, membership numbers at the end of August dipped to 721,000 from June.

----------

Mpac Group PLC - high speed packaging firm - For the six months ended June 30, pretax profit doubles to GBP2.8 million from GBP1.4 million, on revenue which grew 20% year-on-year to GBP44.2 million from GBP36.8 million, supported by a 69% increase in order intake to GBP51.7 million from GBP30.5 million. Segmentally, Original Equipment revenue grew mainly in the America through a full period of trading from Mpac Switchback. Closing order book increased 12% to GBP62.0 million from GBP45.4 million. Will not declare an interim dividend. Looking ahead, expects annual results to exceed current market expectations.

----------

Inspired PLC - Lancashire-based energy procurement consultant - For the first half of 2021, pretax profit dips 1% to GBP935,000 from GBP952,000 a year prior, as administrative expenses rise to GBP22.6 million from GBP18.0 million. This was in spite of revenue growing 31% year-on-year to GBP32.6 million from GBP24.9 million, on a continued recovery in customers, markets and economic activity. Declares dividend of 0.12 pence per share, up 20% from 0.10p a year prior . Looking ahead, remains confident in achieving market expectations, assuming no further Covid-19 disruption.

----------

Camellia PLC - Linton, England-based agricultural production firm - For the six months ended June 30, pretax loss narrows to GBP7.8 million from GBP12.9 million, as administrative costs drop to GBP21.7 million, as did impairment costs. Revenue declined 8.2% year-on-year to GBP105.5 million from GBP114.9 million, as a rise in tea volumes were more than offset by a sharp rise in wages in Assam, and the tea market remaining oversupplied and poorly priced, in addition to a reduced avocado crop and lockdown extensions. Declares interim dividend of 44p per share from none a year prior.

----------

Bidstack Group PLC - London-based in-game advertising platform - For the first half of 2021, pretax loss widens to GBP3.6 million from GBP3.2 million a year prior, due to administrative expenses rising to GBP3.9 million from GBP3.2 million. This is in spite of revenue nearly tripling to GBP820,136 from GBP274,079, through the building up of its portfolio of triple A games, both in the independent and mobile publisher base. Looking ahead, expects revenue for the year as a whole to come in line with market expectations.

----------

600 Group PLC - West Yorkshire, England-based manufacturer and distributor of machine tools, precision engineered components and industrial laser systems - For the year ended March 31, pretax profit is USD90,000, swinging from a loss of USD633,000 the year before, through a fall in net operating expenses to USD17.1 million from USD22.7 million. Meanwhile, revenue for the year declined 20% to USD53.6 million from USD67.2 million, as Covid-19 and the resulting lockdowns had a crippling effect on trading.

----------

Downing Renewables & Infrastructure Trust PLC - investor in solar parks, wind farms and hydroelectric plants - Net asset value per share as at June 30 was 100.2 pence, up 2.2% from 98p at the company's IPO on December 10. Over the period, company has completed two investments, injecting GBP102 million, or 83% of IPO proceeds, leading to portfolio generation of 101,211 megawatt-hours, 6.6% above expectations.

----------

Mast Energy Developments PLC - developer of reserve power generation plants - For the nine months ended June 30, pretax loss widens to GBP1.0 million from GBP220,043, due to heightening administrative costs and one-off listing expenses. Generated no revenue, as the first projects in the UK Reserve Power market are set to come on imminently.

----------

Wentworth Resources PLC - Tanzania-focused natural gas production company - For the first half of 2021, pretax profit more than doubled to USD2.7 million from USD1.2 million, on revenue which grew 40% to USD11.7 million from USD8.3 million, due to a record production performance from Mnazi Bay of 80 million standard cubic feet per day from 58 mmscf a year prior. Looking ahead, reiterates production guidance range for the year at 70 - 80 mmscf per day.

----------

Baron Oil PLC - oil and gas exploration company with assets in the UK, Peru and Timor-Leste - For the first half of 2021, pretax loss narrows to GBP118,000 from GBP705,000 a year prior, due to the lack of an impairment charge and a gain of GBP359,000 on acquiring all shares in SundaGas (Timor-Leste Sahul) Ltd from a 33% interest. In accordance with IFRS3, this has been treated as an effective disposal of the interest. Generates no revenue, as 3D seismic reprocessing to define Chuditch prospectivity is underway. Expects first half of 2022 to be "a key period" for Chuditch and Dunrobin projects.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 May 2019 12:23

Polarean Imaging Confirms USD1 Million Cystic Fibrosis Trial Grant

LONDON (Alliance News) - Polarean Imaging PLC said Tuesday it had its third USD1 million tranche of a study grant confirmed for its late stage trial of xenon medical imaging for children being for

Read more
13 May 2019 10:44

Polarean Imaging Progresses On Clinical Trials, To Add New Trial Site

LONDON (Alliance News) - Polarean Imaging PLC on Monday said that it is progressing on its phase III clinical trials and plans to add an extra site in its lung resection pathway trial to improve a

Read more
29 Apr 2019 11:44

Polarean Imaging Hires Charles Osborne As Chief Financial Officer

LONDON (Alliance News) - Medical imaging firm Polarean Imaging PLC said Monday it has hired Charles Osborne as its new chief financial officer with immediate effect.Osborne is currently the

Read more
29 Apr 2019 09:24

Polarean names Charles Osborne as new CFO

(Sharecast News) - Clinical stage medical-imaging technology outfit Polarean tapped former Innocrin Pharmaceuticals finance boss Charles Osborne Jr to take over as its chief financial officer on Monday.

Read more
1 Apr 2019 16:48

Amphion Innovations Pledges Polarean Shares As Extra Security For Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt in Amphion closed 22%

Read more
11 Mar 2019 18:11

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to

Read more
15 Feb 2019 13:46

Polarean Imaging Wins Polarizer System Order From Canadian University

LONDON (Alliance News) - Medical imaging products manufacturer Polarean Imaging PLC said Friday that it has secured a order for its latest polarizer system from the University of British Columbia

Read more
15 Feb 2019 10:27

Polarean Imaging enters contract with University of British Columbia

(Sharecast News) - Medical imaging technology company Polarean Imaging has entered into a contract for the procurement of its latest polariser system by the University of British Columbia, it announced on Friday, following the conclusion of UBC's procurement process.

Read more
3 Jan 2019 11:45

Amati AIM VCT Builds Over 8% Holding In Polarean Imaging (ALLISS)

LONDON (Alliance News) - Polarean Imaging PLC on Thursday said Amati AIM VCT PLC now holds 8.5% stake in the noble gas polarizer devices manufacturing company.Prior to a transaction on AIM

Read more
11 Dec 2018 13:41

Tuesday broker round-up

(Sharecast News) - ASOS: Morgan Stanley downgrades to underweight with a target price of 3,200p.

Read more
6 Nov 2018 13:55

Polarean Installs Polariser At University Of Missouri, Gets New Order

LONDON (Alliance News) - Polarean Imaging PLC on Tuesday said it installed and commissioned the latest model of its Xenon polariser to the department of Radiology at University of Missouri Health

Read more
3 Oct 2018 10:19

Polarean Imaging Delivers Xenon Polariser To University Of Missouri

LONDON (Alliance News) - Medical technology company Polarean Imaging PLC on Wednesday said the latest model of its Xenon polariser has been delivered to the radiology department at University of

Read more
23 Aug 2018 15:44

UPDATE: Polarean Imaging Enrols First Patient In 129-Xenon MRI Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more
23 Aug 2018 14:53

Polarean Imaging progresses to Phase III trial of hyperpolarised 129-Xenon

(Sharecast News) - Medical imaging technology company Polarean Imaging announced on Thursday that the first patient has been enrolled in its Phase III FDA clinical trial, which aims to demonstrate non-inferiority of its drug-device combination using hyperpolarised 129-Xenon (129Xe) gas MRI, against an approved comparator.

Read more
23 Aug 2018 11:18

Polarean Imaging Enrols First Patient In 129-Xenon MRI Phase III Trial

LONDON (Alliance News) - Polarean Imaging PLC said Thursday it has enrolled the first patient in its phase III clinical trial for 129-Xenon MRI.The study aim to prove the non-inferiority of

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.